No abstract

Microbial infections cause complicated health influences along with bad economic impacts. In the present investigation, three dominant seaweeds namely, Amphiroa anceps, Corallina officinalis and Sargassum filipendula were collected from different Egyptian sites at the Red Sea and Mediterranean Sea during autumn 2019. Organic extracts of the three algae were screened for their antibacterial activity against three pathogenic bacteria Salmonella typhiimurium, Staphylococcus aureus and Escherichia coli, in addition to in vitro antiviral activity against Rotavirus (RV), and Coxsackie virus B3 (CVB3) that cause severe diseases in human. Organic extract of A. anceps, C. officinalis and S. filipendula inhibit E. coli cells by 57.1%, 85.7%, and 91.4%, respectively. The highest level of concentration of the C. officinalis extract (100 µg/mL) inhibits 100% of Staphylococcus aureus cells followed by S. filipendula and A. anceps extract which inhibit 82.5% and 75% of S. aureus. Similarly, the highest concentration of C. officinalis extract inhibits S. typhiimurium by 80%. The extract of A. anceps exhibited a high antiviral effect against RV infection with TI = 22 and virus titers lessened by 2.75 log TCID 50 followed by extractions of C. officinalis with TI = 18.3 and virus titers reduced by 2.5 log TCID 50 . Against CVB3 infection, the extract of A. anceps causes the highest antiviral activity with TI = 15 and reduce the viral titers by 2.5 log TCID 50 , followed by extractions of C. officinalis with TI = 8.8 and inhibition of virus titers by 1.75 log TCID 50 . Extract of S. filipendula displayed the lowest antiviral effects against RV and CVB3 infection with TI = 2.4 and 1.4, respectively. The obtained results clarified that the extract of three marine seaweeds maintains a potent antimicrobial activity, making them a future promising source of new antimicrobial drugs.

The increasing usage of chemical control agents, as well as fungicides to manage plant diseases, causes human and environmental health problems. Macroalgae represent a reservoir for a tremendous variety of secondary metabolites that display a wide range of biological activities. However, their anti-phytopathogenic properties are still being studied. The current study was conducted to investigate whether or not the macroalgae Ulva fasciata extract exhibits antifungal and antiviral activities. In this regard, the organic extracts of U. fasciata were tested for their capabilities against tobacco mosaic virus (TMV) and three molecularly identified fungal isolates, Fusarium verticillioides, Alternaria tenuissima, and Botrytis cinerea with accession numbers OP363619, OP363620, and OP363621, respectively. Among the three tested extract concentrations, 100 µg/mL had the best biological activity against B. cinerea and TMV, with 69.26%and 81.25% inhibition rates, respectively. The HPLC analysis of chemical profiling of the extract showed the presence of a number of phenolic and flavonoid compounds widely known to display many biological activities. In this line, the 4-Hydroxybenzoic acid was the highest phenolic compound (12.3 µg/mL) present in the extract, followed by ferulic acid (9.05 µg/mL). The 7-hydroxyflavone (12.45 µg/mL) was the highest flavonoid in the organic extract of U. faciata followed by rutin, which recorded a concentration of 7.62 µg/ mL. The results of this study show that the U. fasciata extract has antiviral and antifungal properties, which makes it a possible source of natural antimicrobial agents.

No abstract

The increasing use of chemical control agents and pesticides to prevent plant disease has resulted in several human and environmental health problems. Seaweeds, e.g., Amphiroa anceps extracts, have significant antimicrobial activities against different human pathogens. However, their anti-phytopathogenic activities are still being investigated. In the present investigation, three fungal isolates were isolated from root rot and grey mold symptomatic strawberry plants and were molecularly identified by ITS primers to Fusarium culmorum, Rhizoctonia solani, and Botrytis cinerea with accession numbers MN398396, MN398398, and MN398400, respectively. In addition, the organic extract of the red alga Amphiroa anceps was assessed for its antifungal activity against the three identified fungal isolates and tobacco mosaic virus (TMV) infection. At 100 µg/mL, the A. anceps extract had the best biological activity against R. solani, B. cinerea, and TMV infection, with inhibition rates of 66.67%, 40.61%, and 81.5%, respectively. Contrarily, the A. anceps extract exhibited lower activity against F. culmorum, causing inhibition in the fungal mycelia by only 4.4% at the same concentration. The extract’s HPLC analysis revealed the presence of numerous phenolic compounds, including ellagic acid and gallic acid, which had the highest concentrations of 19.05 and 18.36 µg/mL, respectively. In this line, the phytochemical analysis also showed the presence of flavonoids, with the highest concentration recorded for catechin at 12.45 µg/mL. The obtained results revealed for the first time the effect of the A. anceps extract against the plant fungal and viral pathogens, making the seaweed extract a promising source for natural antimicrobial agents.